Financials

Discussions Technicals Seasonals

376270 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

HEM Pharma, Inc. engages in the provision of microbiome solutions. Its products and services include customized healthcare and live biotherapeutic products (LBP) discovery platform services, myLAB, phytobiome, technology transfer, microbiome analysis, and phytochemical solutions. The company was founded on December 30, 2016 and is headquartered in Pohang-si, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

376270 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company